{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:48:31Z","timestamp":1790668111390,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Noncardiac surgery (NCS) following percutaneous coronary intervention (PCI) with stenting is sometimes associated with major adverse cardiac events (MACEs). Second-generation drug-eluting stents (DES) were developed to decrease the incidence of MACE seen with bare metal and first-generation DES.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>The medical records of all adult patients who underwent second-generation DES placement between July 29, 2008 and July 28, 2011 followed by NCS between September 22, 2008 and July 1, 2013 were reviewed. All episodes of MACE following surgery were recorded.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A total of 282 patients (74.8% male) were identified who underwent NCS after PCI with second-generation DES. MACE occurred in 15 patients (5.3%), including 11 deaths. The incidence of MACE changed significantly with time from PCI to NCS: 17.1%, 10.0%, 0.0%, and 3.1% for patients undergoing NCS at 0\u201390, 91\u2013180, 181\u2013365, and \u2265366 days, respectively. Compared with those having NCS \u2265366 days after PCI, the odds ratio for MACE (95% confidence interval) was 6.4 (1.9 to 21.3) at 0\u201390 days and 3.4 (0.8 to 15.3) at 91\u2013180 days. Seven days prior to NCS, 146 (52%) patients were on dual antiplatelet therapy (DAPT), 106 (38%) were on aspirin, and 30 (11%) did not receive antiplatelet therapy. Excessive surgical bleeding occurred in 19 cases (6.7%). While observed bleeding rates were lowest in those not receiving antiplatelet therapy, there were no statistically significant differences based on the presence or absence of antiplatelet therapy (3% [1\/30] for no antiplatelet therapy compared to 6% [6\/106] for aspirin monotherapy and 8% [12\/146] for DAPT; Fisher exact test:\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = .655).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>The incidence of MACE in patients with second-generation DES undergoing NCS was 5.3% and was highest in the first 180 days following DES implantation. The rate of excessive surgical bleeding was 6.7% with the highest observed rate in those on DAPT. However, differences by the presence or absence of antiplatelet therapy were not significant, and future large observational studies will be necessary to further define bleeding risk with continued DAPT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1213\/ane.0000000000003408","type":"journal-article","created":{"date-parts":[[2018,8,31]],"date-time":"2018-08-31T11:47:32Z","timestamp":1535716052000},"page":"621-628","source":"Crossref","is-referenced-by-count":19,"title":["Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents"],"prefix":"10.1213","volume":"128","author":[{"given":"Bradford B.","family":"Smith","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafisseh S.","family":"Warner","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C.","family":"Hanson","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Smith","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charanjit S.","family":"Rihal","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gulati","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm R.","family":"Bell","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Nuttall","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Perioperative Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230812","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1001\/jama.2013.278787","article-title":"Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents.","volume":"310","author":"Hawn","year":"2013","journal-title":"JAMA"},{"key":"R2-20230812","first-page":"e278","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"130","author":"Fleisher","year":"2014","journal-title":"Circulation"},{"key":"R3-20230812","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1093\/eurheartj\/ehu282","article-title":"2014 ESC\/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA).","volume":"35","author":"Kristensen","year":"2014","journal-title":"Eur Heart J"},{"key":"R4-20230812","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/ALN.0b013e318186ddf8","article-title":"Time and cardiac risk of surgery after bare-metal stent percutaneous coronary intervention.","volume":"109","author":"Nuttall","year":"2008","journal-title":"Anesthesiology"},{"key":"R5-20230812","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1097\/ALN.0b013e318186de1c","article-title":"Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents.","volume":"109","author":"Rabbitts","year":"2008","journal-title":"Anesthesiology"},{"key":"R6-20230812","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/hrt.2011.224519","article-title":"Non-cardiac surgery in patients with coronary stents: the RECO study.","volume":"97","author":"Albaladejo","year":"2011","journal-title":"Heart"},{"key":"R7-20230812","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1093\/bja\/ael083","article-title":"Coronary artery stenting and non-cardiac surgery\u2014a prospective outcome study.","volume":"96","author":"Vicenzi","year":"2006","journal-title":"Br J Anaesth"},{"key":"R8-20230812","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/bja\/aev556","article-title":"Effectiveness of platelet inhibition on major adverse cardiac events in non-cardiac surgery after percutaneous coronary intervention: a prospective cohort study.","volume":"116","author":"W\u0105sowicz","year":"2016","journal-title":"Br J Anaesth"},{"key":"R9-20230812","doi-asserted-by":"crossref","first-page":"237","DOI":"10.7326\/M17-2341","article-title":"Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery.","volume":"168","author":"Graham","year":"2018","journal-title":"Ann Intern Med"},{"key":"R10-20230812","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.jacc.2014.12.046","article-title":"Short- versus long-term dual antiplatelet therapy after drug-eluting stent implantation: an individual patient data pairwise and network meta-analysis.","volume":"65","author":"Palmerini","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R11-20230812","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1161\/CIR.0000000000000404","article-title":"2016 ACC\/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF\/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF\/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA\/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC\/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.","volume":"134","author":"Levine","year":"2016","journal-title":"Circulation"},{"key":"R12-20230812","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1016\/j.jacc.2016.09.967","article-title":"Risk associated with surgery within 12 months after coronary drug-eluting stent implantation.","volume":"68","author":"Egholm","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R13-20230812","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1097\/SLA.0000000000001246","article-title":"The incremental risk of coronary stents on postoperative adverse events: a matched cohort study.","volume":"263","author":"Holcomb","year":"2016","journal-title":"Ann Surg"},{"key":"R14-20230812","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.amjcard.2014.04.027","article-title":"Perioperative complications after noncardiac surgery in patients with insertion of second-generation drug-eluting stents.","volume":"114","author":"Lo","year":"2014","journal-title":"Am J Cardiol"},{"key":"R15-20230812","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/CIRCULATIONAHA.112.102715","article-title":"Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study.","volume":"126","author":"Wijeysundera","year":"2012","journal-title":"Circulation"},{"key":"R16-20230812","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1016\/j.jacc.2013.08.725","article-title":"Stent thrombosis with drug-eluting stents: is the paradigm shifting?","volume":"62","author":"Palmerini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R17-20230812","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/ALN.0000000000000451","article-title":"Perioperative management of the patient with a coronary artery stent.","volume":"121","author":"Vetter","year":"2014","journal-title":"Anesthesiology"},{"key":"R18-20230812","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCOUTCOMES.115.002155","article-title":"Risk of adverse cardiac and bleeding events following cardiac and noncardiac surgery in patients with coronary stent: how important is the interplay between stent type and time from stenting to surgery?","volume":"9","author":"Saia","year":"2016","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"R19-20230812","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.","volume":"312","year":"1985","journal-title":"N Engl J Med"},{"key":"R20-20230812","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1161\/CIRCULATIONAHA.107.185700","article-title":"ACC\/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery: Executive Summary: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): Developed in Collaboration With the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.","volume":"116","author":"Fleisher","year":"2007","journal-title":"Circulation"},{"key":"R21-20230812","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.110.015701","article-title":"Development and validation of a risk calculator for prediction of cardiac risk after surgery.","volume":"124","author":"Gupta","year":"2011","journal-title":"Circulation"},{"key":"R22-20230812","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0735-1097(02)02374-4","article-title":"Frequency and correlates of coronary stent thrombosis in the modern era: analysis of a single center registry.","volume":"40","author":"Orford","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"R23-20230812","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients.","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"key":"R24-20230812","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1161\/CIR.0b013e31826e1058","article-title":"Third universal definition of myocardial infarction.","volume":"126","author":"Thygesen","year":"2012","journal-title":"Circulation"},{"key":"R25-20230812","first-page":"e166","article-title":"ACC\/AHA\/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (ACC\/AHA\/SCAI Writing Committee to Update 2001 Guidelines for Percutaneous Coronary Intervention).","volume":"113","author":"Smith","year":"2006","journal-title":"Circulation"},{"key":"R26-20230812","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow.","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"R27-20230812","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1161\/CIRCULATIONAHA.106.613596","article-title":"Cardiogenic shock: current concepts and improving outcomes.","volume":"117","author":"Reynolds","year":"2008","journal-title":"Circulation"},{"key":"R28-20230812","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ijnurstu.2014.09.006","article-title":"Basic statistical reporting for articles published in biomedical journals: the \u201cStatistical Analyses and Methods in the Published Literature\u201d or the SAMPL Guidelines.","volume":"52","author":"Lang","year":"2015","journal-title":"Int J Nurs Stud"},{"key":"R29-20230812","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.058560","article-title":"Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.","volume":"125","author":"R\u00e4ber","year":"2012","journal-title":"Circulation"},{"key":"R30-20230812","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(09)62127-9","article-title":"Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial.","volume":"375","author":"Kedhi","year":"2010","journal-title":"Lancet"},{"key":"R31-20230812","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2147\/vhrm.2008.04.01.31","article-title":"Next-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V).","volume":"4","author":"Sheiban","year":"2008","journal-title":"Vasc Health Risk Manag"},{"key":"R32-20230812","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s12630-012-9782-9","article-title":"Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients.","volume":"59","author":"Beattie","year":"2012","journal-title":"Can J Anaesth"},{"key":"R33-20230812","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1001\/jama.2017.7845","article-title":"Antiplatelet therapy in patients with coronary stents undergoing elective noncardiac surgery: continue, stop, or something in between?","volume":"318","author":"Childers","year":"2017","journal-title":"JAMA"},{"key":"R34-20230812","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1093\/bja\/aem209","article-title":"Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction.","volume":"99","author":"Chassot","year":"2007","journal-title":"Br J Anaesth"},{"key":"R35-20230812","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cjca.2016.09.008","article-title":"Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery.","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"key":"R36-20230812","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/CIRCINTERVENTIONS.111.963728","article-title":"Incidence and outcome of surgical procedures after coronary bare-metal and drug-eluting stent implantation: a report from the CREDO-Kyoto PCI\/CABG registry cohort-2.","volume":"5","author":"Tokushige","year":"2012","journal-title":"Circ Cardiovasc Interv"},{"key":"R37-20230812","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/bja\/aew111","article-title":"Insights into myocardial infarction after noncardiac surgery in patients with a prior coronary artery stent.","volume":"116","author":"Devereaux","year":"2016","journal-title":"Br J Anaesth"},{"key":"R38-20230812","doi-asserted-by":"crossref","first-page":"523","DOI":"10.7326\/0003-4819-154-8-201104190-00003","article-title":"Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study.","volume":"154","author":"Devereaux","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["Anesthesia &amp; Analgesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000539-201904000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:22:09Z","timestamp":1786112529000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000539-201904000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1213\/ane.0000000000003408","relation":{},"ISSN":["0003-2999"],"issn-type":[{"value":"0003-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]}}}